JPRN-UMIN000006489
Completed
未知
A clinical trial evaluating the detection of minimal residual disease (MRD) in patients with chronic myeloid leukemia by DNA-PCR - Clinical trial evaluating detection of minimal residual disease in patients with chronic myeloid leukemia
Juntendo University School of Medicine0 sites3 target enrollmentOctober 5, 2011
Conditionschronic myeloid leukemia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- chronic myeloid leukemia
- Sponsor
- Juntendo University School of Medicine
- Enrollment
- 3
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients whose bone marrow cells or paraffin\-embedded tissue prior to the treatment are not available
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
The behavior intervention on control of glucose among diabetic patientsIRCT20111119008132N7Tabriz University of Medical Sciences90
Recruiting
Phase 3
Assessing the effectiveness of topical peppermint cream and orally ingestible peppermint oxymel mouthwash on halitosis and vomiting of breast cancer patients during chemotherapyBreast cancer patients treated with chemotherapy drugs.Malignant neoplasm of breastIRCT20201219049763N1Iranian academic center for education culture and research225
Not yet recruiting
Phase 2
To evaluate the effectiveness of Amukkara chooranam and aya chenduram in the management of aan maladuHealth Condition 1: - Health Condition 2: - Health Condition 3: N461- OligospermiaCTRI/2024/04/065757DrSESWARI
Recruiting
Not Applicable
The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity.Retinopathy of prematurityJPRN-UMIN000018069Gunma University Hospital Department of Ophthalmology4
Active, not recruiting
Not Applicable
Testing a food supplement for reducing stress on studentsStressMental and Behavioural DisordersISRCTN14084189ROELMI HPC Srl42